The Impact of COVID-19 is included in Metabotropic Glutamate Receptor Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Metabotropic Glutamate Receptor Trends and Forecast
The future of the global metabotropic glutamate receptor market looks promising with opportunities in the attention deficit hyperactivity disorder (ADHD), alzheimerÄX%$%Xs disease, and chronic obstructive pulmonary disease (COPD) markets. The global metabotropic glutamate receptor market is expected to reach an estimated $2.3 billion by 2030 with a CAGR of 11.0% from 2024 to 2030. The major drivers for this market are increase in the prevalence of neurological conditions, growth in disposable income and rise in the worldÄX%$%Xs elderly population.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Metabotropic Glutamate Receptor by Segment
The study includes a forecast for the global metabotropic glutamate receptor by product type, application, and region.
Metabotropic Glutamate Receptor Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:
• mGluR2
• mGluR4
• mGluR5
Metabotropic Glutamate Receptor Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Attention Deficit Hyperactivity Disorder
• AlzheimerÄX%$%Xs Disease
• Chronic Obstructive Pulmonary Disease
Metabotropic Glutamate Receptor Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• Europe
• Asia Pacific
• ROW
List of Metabotropic Glutamate Receptor Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies metabotropic glutamate receptor companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the metabotropic glutamate receptor companies profiled in this report include-
• Eli Lilly and Company
• Novartis International
• Prexton Therapeutics
• Addex Therapeutics
• Taisho Pharmaceutical Holding
• Astrazeneca
• Domain Therapeutic
• Abcam
• Johnson & Johnson
• Medgenic
Metabotropic Glutamate Receptor Market Insights
Lucintel forecasts that mGlur5 is expected to witness highest growth over the forecast period.
North America is expected to witness highest growth over the forecast period due to existence of well-established healthcare infrastructure, rise in research funding, huge patient pool suffering from neurological disorders in the region.
Features of the Global Metabotropic Glutamate Receptor Market
Market Size Estimates: Metabotropic glutamate receptor market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Metabotropic glutamate receptor market size by product type, application, and region in terms of value ($B).
Regional Analysis: Metabotropic glutamate receptor market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product type, application, and regions for the metabotropic glutamate receptor market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the metabotropic glutamate receptor market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the metabotropic glutamate receptor market size?
Answer: The global metabotropic glutamate receptor market is expected to reach an estimated $2.3 billion by 2030.
Q.2 What is the growth forecast for metabotropic glutamate receptor market?
Answer: The global metabotropic glutamate receptor market is expected to grow with a CAGR of 11.0% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the metabotropic glutamate receptor market?
Answer: The major drivers for this market are increase in the prevalence of neurological conditions, growth in disposable income and rise in the worldÄX%$%Xs elderly population.
Q4. What are the major segments for metabotropic glutamate receptor market?
Answer: The future of the global metabotropic glutamate receptor market looks promising with opportunities in the attention deficit hyperactivity disorder (ADHD), alzheimerÄX%$%Xs disease, and chronic obstructive pulmonary disease (COPD) markets.
Q5. Who are the key metabotropic glutamate receptor market companies?
Answer: Some of the key metabotropic glutamate receptor companies are as follows:
• Eli Lilly and Company
• Novartis International
• Prexton Therapeutics
• Addex Therapeutics
• Taisho Pharmaceutical Holding
• Astrazeneca
• Domain Therapeutic
• Abcam
• Johnson & Johnson
• Medgenic
Q6. Which metabotropic glutamate receptor market segment will be the largest in future?
Answer: Lucintel forecasts that mGlur5 is expected to witness highest growth over the forecast period.
Q7. In metabotropic glutamate receptor market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to existence of well-established healthcare infrastructure, rise in research funding, huge patient pool suffering from neurological disorders in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the metabotropic glutamate receptor market by product type (mGlur2, mGlur4, and mGlur5), application (attention deficit hyperactivity disorder, alzheimerÄX%$%Xs disease, and chronic obstructive pulmonary disease), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Metabotropic Glutamate Receptor Market, Metabotropic Glutamate Receptor Market Size, Metabotropic Glutamate Receptor Market Growth, Metabotropic Glutamate Receptor Market Analysis, Metabotropic Glutamate Receptor Market Report, Metabotropic Glutamate Receptor Market Share, Metabotropic Glutamate Receptor Market Trends, Metabotropic Glutamate Receptor Market Forecast, Metabotropic Glutamate Receptor Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Metabotropic Glutamate Receptor Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Metabotropic Glutamate Receptor Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Metabotropic Glutamate Receptor Market by Product Type
3.3.1: mGluR2
3.3.2: mGluR4
3.3.3: mGluR5
3.4: Global Metabotropic Glutamate Receptor Market by Application
3.4.1: Attention Deficit Hyperactivity Disorder (ADHD)
3.4.2: AlzheimerÄX%$%Xs Disease
3.4.3: Chronic Obstructive Pulmonary Disease (COPD)
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Metabotropic Glutamate Receptor Market by Region
4.2: North American Metabotropic Glutamate Receptor Market
4.2.2: North American Metabotropic Glutamate Receptor Market by Application: Attention Deficit Hyperactivity Disorder, AlzheimerÄX%$%Xs Disease, and Chronic Obstructive Pulmonary Disease
4.3: European Metabotropic Glutamate Receptor Market
4.3.1: European Metabotropic Glutamate Receptor Market by Product Type: mGluR2, mGluR4, and mGluR5
4.3.2: European Metabotropic Glutamate Receptor Market by Application: Attention Deficit Hyperactivity Disorder, AlzheimerÄX%$%Xs Disease, and Chronic Obstructive Pulmonary Disease
4.4: APAC Metabotropic Glutamate Receptor Market
4.4.1: APAC Metabotropic Glutamate Receptor Market by Product Type: mGluR2, mGluR4, and mGluR5
4.4.2: APAC Metabotropic Glutamate Receptor Market by Application: Attention Deficit Hyperactivity Disorder, AlzheimerÄX%$%Xs Disease, and Chronic Obstructive Pulmonary Disease
4.5: ROW Metabotropic Glutamate Receptor Market
4.5.1: ROW Metabotropic Glutamate Receptor Market by Product Type: mGluR2, mGluR4, and mGluR5
4.5.2: ROW Metabotropic Glutamate Receptor Market by Application: Attention Deficit Hyperactivity Disorder, AlzheimerÄX%$%Xs Disease,and Chronic Obstructive Pulmonary Disease
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Metabotropic Glutamate Receptor Market by Product Type
6.1.2: Growth Opportunities for the Global Metabotropic Glutamate Receptor Market by Application
6.1.3: Growth Opportunities for the Global Metabotropic Glutamate Receptor Market by Region
6.2: Emerging Trends in the Global Metabotropic Glutamate Receptor Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Metabotropic Glutamate Receptor Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Metabotropic Glutamate Receptor Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Eli Lilly and Company
7.2: Novartis International
7.3: Prexton Therapeutics
7.4: Addex Therapeutics
7.5: Taisho Pharmaceutical Holding
7.6: Astrazeneca
7.7: Domain Therapeutic
7.8: Abcam
7.9: Johnson & Johnson
7.10: Medgenic
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Metabotropic Glutamate Receptor Market Report.